Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 11.43 as of Tuesday, August 4, 2026.
Forward PE Ratio (11.43) = Close Price ($95.09) / Consensus Forward EPS ($8.49)
FORWARD PE RATIO
11.43
SECTOR MEDIAN · HEALTHCARE
19.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-41.02%
vs the sector median at left
Zimmer Biomet Holdings, Inc.
Market Cap
$18.40B
Forward PE Ratio
11.43
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.40B | 11.43 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.21 |
| Viatris Inc. (VTRS)vs › | $20.30B | 7.20 |
| Medpace Holdings, Inc. (MEDP)vs › | $15.91B | 32.57 |
| Solventum Corporation (SOLV)vs › | $15.16B | 13.44 |
| United Therapeutics Corporation (UTHR)vs › | $21.95B | 18.52 |
| DaVita Inc. (DVA)vs › | $14.78B | 15.70 |
| Moderna, Inc. (MRNA)vs › | $22.38B | N/A |
| The Cooper Companies, Inc. (COO)vs › | $14.40B | 16.03 |
| Baxter International Inc. (BAX)vs › | $14.35B | 13.93 |
Trailing P/E
25.2
reported TTM EPS
Forward P/E
11.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $8.49 implies +120.5% EPS growth vs the reported trailing $3.85.
At today's $95.09 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $8.49 | $8.36 – $8.53 | 16 | 11.2x |
| 2027-12-31 | $9.01 | $8.52 – $9.28 | 16 | 10.6x |
| 2028-12-31 | $9.64 | $7.70 – $11.40 | 8 | 9.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
